aiqbench analysis
This study demonstrates the efficacy of machine learning classifiers in extracting acoustic biomarkers from spontaneous speech to distinguish Alzheimer's patients from healthy controls with high discriminative power. By leveraging low-level descriptors of prosody, spectral content, and timing, the research validates non-invasive audio-based screening as a viable tool for early dementia detection. The work advances the intersection of signal processing and machine learning applications in clinical diagnostics.
Acoustic Biomarkers for Alzheimer's Disease Detection from Spontaneous Speech
arXiv:2610.12500v1 Announce Type: cross Abstract: Alzheimer's disease (AD) remains a major public health challenge, and early identification is crucial for timely intervention and care planning. Recent work has shown that speech-based digital biomarkers can capture subtle changes in vocal production, prosody, and timing that often precede or accompany cognitive decline. In this study, we investigate whether acoustic features extracted from spontaneous speech can reliably distinguish individuals with AD from healthy controls. Using a structured speech dataset derived from the Cookie Theft picture-description task, we extract clinically informative low-level descriptors spanning prosodic, spectral, and temporal domains, and evaluate a range of machine learning classifiers. Our results indicate that acoustic biomarkers carry strong discriminative value, with the best-performing models achieving clinically meaningful separation between diagnostic groups. These findings support the use of non-invasive, low-cost audio-based screening tools and motivate further work on multimodal and longitudinal assessment frameworks for dementia risk detection.
Abstract:Alzheimer's disease (AD) remains a major public health challenge, and early identification is crucial for timely intervention and care planning. Recent work has shown that speech-based digital biomarkers can capture subtle changes in vocal production, prosody, and timing that often precede or accompany cognitive decline. In this study, we investigate whether acoustic features extracted from spontaneous speech can reliably distinguish individuals with AD from healthy controls. Using a structured speech dataset derived from the Cookie Theft picture-description task, we extract clinically informative low-level descriptors spanning prosodic, spectral, and temporal domains, and evaluate a range of machine learning classifiers. Our results indicate that acoustic biomarkers carry strong discriminative value, with the best-performing models achieving clinically meaningful separation between diagnostic groups. These findings support the use of non-invasive, low-cost audio-based screening tools and motivate further work on multimodal and longitudinal assessment frameworks for dementia risk detection.
Audio and Speech Processing (eess.AS); Machine Learning (cs.LG); Sound (cs.SD)
arXiv:2610.12500 [eess.AS]
(or arXiv:2610.12500v1 [eess.AS] for this version)
https://doi.org/10.48550/arXiv.2610.12500 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 243 words
Related coverage
Dementia classification from spontaneous speech using wrapper-based feature selection
arXiv · Jul 28, 2026
Disentangling Acoustic Cues in Alzheimer's Pathology and Perception: The Roles of Language and Gender
arXiv · Jul 28, 2026
Explainable and Generalisable LLM-based Cognitive Decline Detection with Spontaneous Speech
arXiv · Sep 30, 2026
Early Detection of Alzheimer's Disease Using Explainable Machine Learning on Clinical Biomarkers: A Multi-Class Classification Study Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset
arXiv · Jun 5, 2026